Home
Esportazione
Statistica
Opzioni
Visualizza tutti i metadati (visione tecnica)
Would the combination of everolimus with endocrine-therapy help in FGFR2 positive serous endometrial cancer?
Cappelletti, Maria Rosa
•
Gnetti, Letizia
•
Santini, Daniele
altro
GENERALI, DANIELE
2015
journal article
Periodico
ONCOSCIENCE
Abstract
N/A
DOI
10.18632/oncoscience.168
Archivio
http://hdl.handle.net/11368/2903837
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84958544242
http://www.impactjournals.com/oncoscience/index.php?pii=168
Diritti
open access
license:creative commons
license uri:http://creativecommons.org/licenses/by/3.0/it/
FVG url
https://arts.units.it/bitstream/11368/2903837/2/Combination_of_everolimus.pdf
Soggetti
Endometrial cancer
Everolimu
FGFR inhibitor
FGFR2
Cancer Research
Oncology
Scopus© citazioni
1
Data di acquisizione
Jun 7, 2022
Vedi dettagli
google-scholar
Vedi dettagli